Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Moderna Inc (NQ: MRNA )

43.06 -0.33 (-0.76%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
If You Invested $10,000 in Moderna in 2019, This Is How Much You Would Have Today
Moderna generated billions of dollars in earnings from its coronavirus vaccine. 
Via The Motley Fool
Exposures COVID-19
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine... 
Via Benzinga
Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Via ACCESSWIRE
3 Doomed Nasdaq Stocks to Dump Before They Dive: February 2024
Investors would be smart to steer clear of these companies, each of which is facing problems that seem insurmountable. 
Via InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system. 
Via Benzinga
Topics Economy
Exposures Interest Rates
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
Via Benzinga
1 Stock Down 43% to Buy and Hold for 10 Years
This biotech isn't just a pandemic stock. 
Via The Motley Fool
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a... 
Via Benzinga
Exposures COVID-19
Moderna to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024
Via ACCESSWIRE
Moderna Named to Fortune's List of World's Most Admired Companies
Via ACCESSWIRE
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions. 
Via Benzinga
Behind the Scenes of Moderna's Latest Options Trends
Via Benzinga
3 Things That Could Help 2023 Loser-Stock Moderna Roar Higher in 2024
Moderna may be heading for a new era of growth. 
Via The Motley Fool
Peering Into Moderna's Recent Short Interest
Via Benzinga
Critical Insights From Moderna Analyst Ratings: What You Need To Know
Via Benzinga
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
The stock is high risk, but rewards could be great if all works out well for Novavax. 
Via The Motley Fool
My Top-5 AI Growth Stocks to Buy Hand Over Fist for 2024
These stocks could deliver top returns now and well into the future. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Growth Stock Down 79% That's a Screaming Buy Right Now, According to Several Wall Street Analysts
This biotech's prospects go well beyond COVID-19. 
Via The Motley Fool
3 S&P 500 Stocks With 127% to 170% Upside in 2024, According to Select Wall Street Analysts
Wall Street's benchmark index is comprised of 500 companies, three of which could deliver triple-digit upside in the new year. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Highlights From the 2024 JPMorgan Health Care Conference
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. 
Via The Motley Fool
If You Invested $10,000 in Moderna at the End of 2019, This Is How Much You Would Have Today
Has the stock wiped out its gains since the pandemic? 
Via The Motley Fool
Better Bull Market Buy: Pfizer vs. Moderna
There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks. 
Via The Motley Fool
Exposures COVID-19
3 Stocks Poised to Bounce Back After a Brutal 2023
These companies, which badly lagged the market last year, now look to be turning things around and could be rebound stocks in the year ahead. 
Via InvestorPlace
Alphabet, Electronic Arts And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by over 90 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
7 Mighty Healthcare Stocks Changing the Game of Medicine
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks. 
Via InvestorPlace
3 Struggling Businesses Investors Shouldn't Gamble on This Year
These stocks all crashed heavily in 2023, and there is no reason to expect things will get a whole lot better this year. 
Via The Motley Fool
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here. 
Via Benzinga
7 Healthcare Stocks Taking Medicine to the Next Level
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider. 
Via InvestorPlace
3 Megatrend Stocks that Will Revolutionize Your Portfolio
Consider these powerhouse stocks for likely significant capital appreciation, growth, and rewards for your portfolio. 
Via InvestorPlace
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.